173 related articles for article (PubMed ID: 37950809)
1. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.
Chen L; Zhao Y; Li M; Lv G
Hepatol Int; 2024 Apr; 18(2):517-528. PubMed ID: 37950809
[TBL] [Abstract][Full Text] [Related]
2. Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study.
Dong X; Gong LL; Hong MZ; Pan JS
BMC Gastroenterol; 2024 Feb; 24(1):77. PubMed ID: 38373892
[TBL] [Abstract][Full Text] [Related]
3. Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study.
Zhang W; Lang R
Front Immunol; 2023; 14():1276459. PubMed ID: 37928559
[TBL] [Abstract][Full Text] [Related]
4. Primary sclerosing cholangitis causally affects kidney function decline: A Mendelian randomization study.
Cho JM; Koh JH; Kim SG; Lee S; Kim Y; Cho S; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK; Park S
J Gastroenterol Hepatol; 2024 Jan; 39(1):185-192. PubMed ID: 37726875
[TBL] [Abstract][Full Text] [Related]
5. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study.
Gao W; Peng C; Wang Z; Li Y; Liu M
J Transl Med; 2024 May; 22(1):425. PubMed ID: 38704596
[TBL] [Abstract][Full Text] [Related]
6. Genetically predicted gut microbiota mediate the association between plasma lipidomics and primary sclerosing cholangitis.
Zhou J; Zhu D; Xu Y; Chen C; Wang K
BMC Gastroenterol; 2024 May; 24(1):158. PubMed ID: 38720308
[TBL] [Abstract][Full Text] [Related]
7. A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis.
Liang X; Wang Z; Shu Q; Huang X; Wang J; Wu J; Liu N; Xie N
Eur J Gastroenterol Hepatol; 2024 Feb; 36(2):147-154. PubMed ID: 38131422
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
9. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study.
Fu Y; Li J; Zhu Y; Chen C; Liu J; Gu S; Zheng Y; Li Y
BMC Med Genomics; 2023 Oct; 16(1):232. PubMed ID: 37789337
[TBL] [Abstract][Full Text] [Related]
10. Association between gut microbiota and autoimmune cholestatic liver disease, a Mendelian randomization study.
Cui Y; Guo Y; Kong Y; Zhang G
Front Microbiol; 2024; 15():1348027. PubMed ID: 38601930
[TBL] [Abstract][Full Text] [Related]
11. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
[TBL] [Abstract][Full Text] [Related]
12. Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study.
Yang J; Ma G; Wang K; Yang H; Jiang S; Fan Q; Zhou X; Guo G; Han Y
Front Med (Lausanne); 2024; 11():1342119. PubMed ID: 38327703
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
14. How genetic risk contributes to autoimmune liver disease.
Ellinghaus D
Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
[TBL] [Abstract][Full Text] [Related]
15. Genetic link between rheumatoid arthritis and autoimmune liver diseases: A two-sample Mendelian randomization study.
Fan J; Jiang T; He D
Semin Arthritis Rheum; 2023 Feb; 58():152142. PubMed ID: 36446255
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into autoimmune liver diseases provided by genome-wide association studies.
Mells GF; Kaser A; Karlsen TH
J Autoimmun; 2013 Oct; 46():41-54. PubMed ID: 23931959
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
[TBL] [Abstract][Full Text] [Related]
18. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
19.
Zecher BF; Ellinghaus D; Schloer S; Niehrs A; Padoan B; Baumdick ME; Yuki Y; Martin MP; Glow D; Schröder-Schwarz J; Niersch J; Brias S; Müller LM; Habermann R; Kretschmer P; Früh T; Dänekas J; Wehmeyer MH; Poch T; Sebode M; ; Ellinghaus E; Degenhardt F; Körner C; Hoelzemer A; Fehse B; Oldhafer KJ; Schumacher U; Sauter G; Carrington M; Franke A; Bunders MJ; Schramm C; Altfeld M
Gut; 2024 Jan; 73(2):325-337. PubMed ID: 37788895
[TBL] [Abstract][Full Text] [Related]
20. Causal association between autoimmune liver disease and Sjögren's syndrome: A Mendelian randomization study.
Li Y; Wang J; Jiang H; Zhang J; Qi J; Jiang Z; Chen L; Ying Z
Int J Rheum Dis; 2024 May; 27(5):e15151. PubMed ID: 38720573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
